(Q39461967)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8873693%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

title

Pharmacokinetic and pharmacodynamic profiles of sumatriptan in migraine patients with headache recurrence or no response (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8873693%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

1 reference

1 reference

1 reference

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8873693%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

7

Ferrari MD

1 reference

20 October 2019

Visser WH

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8873693%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

Burggraaf J

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8873693%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

Muller LM

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8873693%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

Fowler PA

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8873693%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

Cohen AF

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8873693%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

language of work or name

English

0 references

publication date

1 October 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8873693%20AND%20SRC:MED&resulttype=core&format=json

Clinical Pharmacology & Therapeutics

20 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8873693%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

volume

60

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8873693%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8873693%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

page(s)

452-460

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8873693%20AND%20SRC:MED&resulttype=core&format=json

Sumatriptan in clinical practice: a 2-year review of 453 migraine patients

20 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990202-7

Treatment of migraine attacks with sumatriptan. The Subcutaneous Sumatriptan International Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990202-7

Sumatriptan. A reappraisal of its pharmacology and therapeutic efficacy in the acute treatment of migraine and cluster headache

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990202-7

Clinical and experimental effects of sumatriptan in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990202-7

5-HT1 receptors in migraine pathophysiology and treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990202-7

Risk factors for headache recurrence after sumatriptan: a study in 366 migraine patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990202-7

Sumatriptan-nonresponders: a survey in 366 migraine patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990202-7

The Clinical Pharmacology, Pharmacokinetics and Metabolism of Sumatriptan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990202-7

Sumatriptan clinical pharmacokinetics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990202-7

Single dose pharmacokinetics of sumatriptan in healthy volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990202-7

Mode of action of the anti-migraine drug sumatriptan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990202-7

Neurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990202-7

Migraine pain associated with middle cerebral artery dilatation: reversal by sumatriptan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990202-7

Antimigraine drug sumatriptan increases blood flow velocity in large cerebral arteries during migraine attacks

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990202-7

Cerebral blood flow during migraine attacks without aura and effect of sumatriptan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990202-7

Flunarizine in prophylaxis of childhood migraine. A double-blind, placebo-controlled, crossover study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990202-7

Determination of sumatriptan succinate in plasma and urine by high-performance liquid chromatography with electrochemical detection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990202-7

Cerebral Blood Flow Velocities are Reduced During Attacks of Unilateral Migraine Without Aura

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990202-7